Accepting applications until August 1
Accepting applications until August 1
Xingxin Ouyang, Hao Liu, Huimin Jin .
Data on female breast cancer incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021 were obtained from the Global Burden of Disease 2021 study. Trends were analyzed for two age groups (20-54 and ≥55 yea... Read More
Daniel Redondo-Sánchez 1, Dafina Petrova 2, Jàmnica Bigorra 3, et al.
This collaborative study within the Spanish Network of Cancer Registries (REDECAN) aimed to examine cancer incidence trends in young adults in Spain. A total of 153,599 new cancer cases (58% in women) were diagnosed during the stu... Read More
Jamie M Reedy, Nancy A Borstelmann, Veda N Giri.
There has been a concerning 79.1% global rise in incidence between 1990 and 2019 of early onset cancer (EOC), defined as cancers diagnosed under age 50. EOC diagnoses now account for 12% of all cancer diagnoses. The largest increa... Read More
Karim Abdel Wahab, Ahmed Hassan, Ahmed Morsi, et al.
In Egypt, there were 150,578 new cancer cases and 95,275 cancer deaths in 2022, indicating a substantial burden on patients and the healthcare system. In 2019, Egypt had a total of 45,114 deaths, from liver, lung, breast, cervical... Read More
Leonor Vasconcelos de Matos, Margarida Borges, Ana Teresa Oliveira, et al.
This study aimed to characterize the employment status and work-related conditions of patients with advanced breast cancer (ABC) in Portugal and quantify the productivity costs of premature abandonment of the work market while eva... Read More
Ehsan Ullah, Hikmat Abdel-Razeq, Sana Bentebbal, et al.
The Middle East and North African (MENA) region broadly mirrors global cancer trends, with breast cancer remaining the most common cancer among women. However, regional differences in germline BRCA1/2 mutation prevalence suggest t... Read More
Xin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
Risk-based breast cancer (BC) screening can provide tailored recommendations based on individual risk. We estimated 10-year BC risks in 3753 women aged 40-70 with no cancer history. The primary endpoint was risk reclassification,... Read More
Pansa Intaram, Surachai Phimha, Prapassara Sirikarn, et al.
Data were collected from 404 participants, comprising 202 pairs of breast cancer patients and their caregivers across Health Region 9 during six months from September 2024 to February 2025. All the patients were female with a mean... Read More
Xiaoyang Du, Leo Gkekos, Balram Rai, et al.
With new emerging technologies for diagnostics and treatment for breast cancer, there is a demand for updated breast cancer costs based on current clinical practice. 82,960 breast cancer patients diagnosed since 2008 were alive by... Read More
Piotr Artur Winciunas, Justyna Grudziąż-Sękowska, Agnieszka Mazurek, et al.
Sickness absence due to breast cancer generates significant indirect costs. The number of sick leave days due to breast cancer in Poland varied from 1,241,223 in 2021 to 1,444,863 in 2024. The number of sick leave certificates inc... Read More
Aline Cristini Vieira, Matheus Costa E Silva, et al.
Financial toxicity (FT) refers to the negative impact of the financial burden of cancer diagnosis and treatment on patients' well-being. With rising global costs of oncologic therapies, diagnostics, and supportive care, FT ha... Read More
Erin Comerford, Sukyung Chung, Marlon Graf, et al.
Caring for a patient with metastatic breast cancer (mBC) can impose a substantial burden and can lead to significant productivity losses. One in three caregivers changed work status after onset of caregiving, either reducing worki... Read More